Keiichi Ozono, MD

ISEIKAI International General Hospital
Osaka, Japan

Disclosure information not submitted.

Presentation(s):

• SAT-742 - Real-world biochemical effectiveness in patients with XLH treated with burosumab or phosphate and vitamin D

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• ORF16-04 - Encaleret Restores Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1 (ADH1): Primary Results from the Phase 3 CALIBRATE Trial

  Saturday, June 13, 2026
  2:00 PM - 2:15 PM CT